Status:
NOT_YET_RECRUITING
Sildosin as a Male Contraceptive Non Hormonal
Lead Sponsor:
Benha University
Conditions:
Contraception Use
Eligibility:
MALE
20+ years
Phase:
PHASE1
Brief Summary
In all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded. Follow up data...
Eligibility Criteria
Inclusion
- male sexually active
Exclusion
- male on oral contraceptives Male with female partner on contraceptives
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07195097
Start Date
September 1 2025
End Date
December 1 2025
Last Update
September 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.